Arthritis/rheumatic disorders:
Indications for: RIDAURA
Active rheumatoid arthritis unresponsive to NSAIDs.
Adult Dosage:
Initially 6mg daily in 1–2 divided doses. If response inadequate after 6 months, may increase to 3mg 3 times daily. If still ineffective after 3 months, discontinue.
Children Dosage:
Not recommended.
RIDAURA Contraindications:
History of gold-induced disorders.
Boxed Warning:
Gold toxicity. Physicians should be experienced in chrysotherapy.
RIDAURA Warnings/Precautions:
Be fully familiar with chrysotherapy and this product's toxicity and benefits before use. Impaired renal or hepatic function. Inflammatory bowel disease. Rash. History of bone marrow depression. Monitor CBC with differential, platelet count, urinalysis, renal, liver function and for GI bleeding. Discontinue immediately if thrombocytopenia, proteinuria, or hematuria occurs. Pregnancy (Cat.C), nursing mothers: not recommended.
RIDAURA Classification:
DMARD (gold salt).
Adverse Reactions:
Bone marrow depression, proteinuria, hematuria, diarrhea, GI upset, ulcerative colitis, rash, pruritus, exfoliative dermatitis, stomatitis, conjunctivitis, proteinuria, nephrotic syndrome, cholestatic jaundice, gold bronchitis, pneumonitis, peripheral neuropathy.
How Supplied:
Caps—60
